Novartis

Senators ask FDA for biosimliar naming rules

Soonish would be good, since a Novartis subsidiary filed a biosimilar with the FDA last month.

Business briefs: Layoffs at Roche and Merck, plus pipeline news

Merck and Roche Diagnostics announce job cuts; Novartis abandons an Afinitor study; an FDA advisory committee gives Bayer's lung drug the nod; Vivus still has no plans for Qsymia DTC; and Isis drops development of a mid-stage RA drug

Email Newsletters

MM&M inVISION